Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MIT team aims to reduce chemo doses

07.01.2005


MIT biologists report a potential way to decrease the dose of chemotherapeutic agents needed to tackle cancer, a feat that would reduce these agents’ toxic side effects.



What makes cancer cells unique is that they divide at a faster rate than ordinary cells, which makes them susceptible to the action of chemotherapeutic agents. But although chemotherapy is an effective treatment against fast-growing tumors, it is also associated with numerous toxic side effects because it is required at high doses to be effective.

Researchers from MIT’s Center for Cancer Research (CCR) suggest a new approach to achieving the same response using a lower dose of chemotherapy, thereby limiting the harmful side effects of the drugs. Their approach involves making cancer cells even more sensitive to these agents.


In a paper to be published in the January 7, 2005 issue of Molecular Cell, a CCR research team led by Michael Yaffe, the Howard S. and Linda B. Stern Associate Professor of Biology, reports its results showing that blocking the function of the protein MAPKAP Kinase-2 increases the sensitivity of cancer cells to certain types of cancer treatment.

"MAPKAP Kinase-2 had been previously studied and was thought to be primarily involved in inflammation," explains Yaffe, who is also a member of the Department of Surgery at Beth Israel Deaconess Medical Center. "But our work shows that MAPKAP Kinase-2 also integrates DNA damage signaling responses and cell cycle arrest in mammalian cells."

"This result is particularly exciting as several drug companies are already developing MAPKAP Kinase-2 inhibitors for use in inflammation," said Yaffe. "Our hope is that we can use drugs already in development as anti-cancer agents."

Normal cells have a remarkable ability to sense when their DNA has been damaged and will repair the problem before continuing to copy their DNA and divide.

Using RNA interference (RNAi) to inhibit the activity of MAPKAP Kinase-2, Biology graduate student Isaac Manke showed that cells no longer sense DNA damage caused by ultraviolet light. Instead, he found the cells are more sensitive to the killing effects of ultraviolet light and also divide much faster.

"The discovery that MAPKAP Kinase-2 pathway functions to coordinate cell division and the DNA damage repair process is remarkable in its similarity to other pathways involved in the response to other types of DNA damage," said Manke.

In fact, clinical trials are underway to test the effectiveness of combining a drug that blocks the DNA damage response with chemotherapy to see if lower doses of chemotherapeutic agents may be used. The results of this MIT study suggest yet another new approach for improving a patient’s response to chemotherapy.

Other MIT CCR researchers include postdoctoral fellows Daniel Lim and Mary Stewart, former postdoctoral fellow Anhco Nguyen and graduate student Andrew Elia.

Support for this work comes from the Jane Coffin Childs Foundation, the National Institutes of Health and the Burroughs-Wellcome Fund. Manke is supported by a Koch Graduate Fellowship.

Elizabeth A. Thomson | MIT News Office
Further information:
http://www.mit.edu

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>